ISB News

PROJECT BIOTECH Summer Camp Report

PROJECT BIOTECH Camp goers

Photo above: Students participating in PROJECT BIOTECH Summer Camp. Photo credit: Shoreline Community College

By Dina Kovarik
Project Manager, Baliga Lab

The Shoreline Community College (SCC) Biotech Program and the Amgen Biotech Experience (ABE) program partnered with the Institute for Systems Biology (ISB) to develop a one‐week summer camp for high school students called PROJECT BIOTECH. The camp took place at SCC on July 7‐11, 2014. While the Puget Sound region is home to many diverse summer camp experiences for teenagers, few focus exclusively on the life sciences (i.e. biology and biotechnology).

PROJECT BIOTECH was designed to provide an immersive science experience for up to 24 campers. The program covered biotechnology curricula from the ABE program and bioinformatics curricula from the Northwest Association for Biomedical Research and Digital World Biology. The camp also includes science, technology, engineering and mathematics (STEM) career exploration activities, such as panel discussions with local STEM professionals. PROJECT BIOTECH is administered by ABE Program Manager Adrienne Houck, ISB Project Manager Dr. Dina Kovarik, and PROJECT BIOTECH Program Coordinator Dr. Reitha Weeks, in consultation with Dr. Guy Hamilton, Biology/Biotechnology Program Chair at SCC.

The goal of PROJECT BIOTECH is to provide high school students:

  • Hands‐on, authentic biotechnology laboratory
    experiences
  • An understanding of bioinformatics – how computers are used to organize and analyze biological information
  • Exploration of STEM‐related careers, educational opportunities at SCC, and career opportunities in the Puget Sound biotechnology community

Over the course of the week, campers learned common biotechnology and molecular biology techniques using DNA cloning of red fluorescent protein and DNA barcoding as models. With ages ranging from 13 to 18 years old, campers learned the importance of collaboration by working together with lab partners throughout the week. Students began the week by practicing their micropipetting skills making “suncatchers” with food coloring and 96‐well plates and purifying DNA from their cheek cells. By the end of Day 1, campers had also learned about plasmid DNA, restriction digestion, gel extraction, and agarose gel electrophoresis.

On the final day of the camp, parents, teachers, friends, staff, and members of the education, political, and biotechnology communities came together to learn from campers about the highlights of the week – what they learned and what they enjoyed the most.

Watch the PROJECT BIOTECH video.

PROJECT BIOTECH was made possible through the support of Novo Nordisk, Dendreon Corp., Illumina, Inc., and Amnis/EMD Millipore. A sponsorship was also provided by Travelmore/Travel Leaders.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.